ASK REDCHAT ANYTHING ABOUT SYNAPTOGENIX INC.
Synaptogenix Inc. (BATS: SNPX)
Listen to this Section
$24.55
N/A
(
0% )
11.5K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Bryostatin-1DetailsAlzheimer's disease |
Phase 2b |
| Bryostatin-1DetailsFragile X syndrome |
Failed |
Market Data
|
| Open |
$24.55 |
| Previous Close |
$24.55 |
| Volume |
11.5K |
| Market Cap |
N/A |
| Day Range |
$24.02 - $24.70 |
| 52 Week Range |
$2.05 - $43.54 |
| Shares Outstanding |
N/A |
| Change % |
0% |
| Net Change |
N/A |
| Insider Ownership |
N/A |
| Exchange |
BATS |
| Sector | Healthcare |
| Industry | Medicinal Chemicals and Botanical Products |
| IPO Year | 2025 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-3,200.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-04-10 |
Sale |
-800.00 |
Bernstein Bruce |
| 2024-04-10 |
Sale |
-800.00 |
SCHECHTER JONATHAN |
| 2024-04-10 |
Sale |
-800.00 |
Silverman Joshua |
| 2024-04-10 |
Sale |
-800.00 |
Singer William S. |